You are here: Industry Insights > Twist Bioscience

News List

Twist Bioscience, Artisan Development Labs partner to discover cell therapies pharmaceutical-business-review.
January 26, 2022
Twist Bioscience has teamed up with Artisan Development Labs to discover new antibodies against five undisclosed targets.
Twist Bioscience launches new company for Covid-19 antibody treatments Pharmaceutical-Technology
November 17, 2021
Twist Bioscience has announced the formation of an independently operated biotechnology company, Revelar Biotherapeutics, which will develop and market new Covid-19 and other antibody therapies...
Twist Alliance Pan-Cancer Methylation Panel Global Launch Event - A Strategic Collaboration Between AnchorDx and Twist Bioscience for Pan-Cancer Liquid Biopsy prnasia
October 13, 2021
The Twist Alliance Pan-Cancer Methylation Panel (Pan-Cancer Panel), a solution for pan-cancer study including DNA methylation library preparation and targeted enrichment for next-generation sequencing (NGS)...
Twist Bioscience announces potent SARS-CoV-2 neutralising data from Covid-19 therapeutic antibody programme pharmaceutical-business-review
September 08, 2020
Twist Bioscience announced data demonstrating the potent neutralizing effects of multiple potential therapeutic antibodies, both Immunoglobulin G (IgG) antibodies and substantially smaller single domain VHH “nanobodies,” against SARS-CoV-2, the virus ...
Seismic Bio partners with Twist Bioscience for discovery and optimisation of antibodies pharmaceutical-business-review
August 07, 2020
Twist Bioscience Corporation and Seismic Bio announced a partnership for the discovery and optimization of antibodies to high-value immuno-oncology targets.
Twist Bioscience identifies competitive antibodies for SARS-CoV-2 pharmaceutical-business-review
May 11, 2020
Twist Bioscience reported it has identified competitive antibodies to SARS-CoV-2, the virus that causes COVID-19, which could potentially be used for diagnostic tests or therapeutic treatments.
Twist Bioscience announces strategic collaboration with Schrödinger for drug discovery pharmaceutical-business-review
January 19, 2020
Twist Bioscience, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a collaboration with Schrödinger, a company focused on transforming the way therapeutics are discovered with
Twist Bioscience, LakePharma Form Collaboration contractpharma
April 09, 2019
Twist Bioscience, LakePharma Form Collaboration